|

Carvedilol 3.125 mg Clinical Trials

1 actively recruiting trial

Top Sponsors

  • Post Graduate Institute of Medical Education and Research, Chandigarh1

Indications

  • Decompensated Cirrhosis1
  • Cirrhotic Cardiomyopathy1
  • Left Ventricular Diastolic Dysfunction1
  • Liver Disease1
  • Heart Disease1

Other1 trial

Carvedilol + Simvastatin vs. Carvedilol Alone for Cirrhosis and Cirrhotic Cardiomyopathy and Impact on Hepatic Decompensation and Survival
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.